LRRK2 and Parkinson disease: Recently, GCase activity of induced pluripotent stem cell (iPSC)-derived dopamine neurons from LRRK2-PD patients, carrying either the G2019S or the R1441C mutations, was found to be reduced compared to neurons from healthy controls, suggesting a negative correlation between these two activities16.